Opportunity
DIBBS #SPE2DP-26-T-2848
DLA Solicitation for Meloxicam Tablets (15 mg, 100-count bottles) for Multiple Military Locations
Posted
April 13, 2026
Respond By
April 20, 2026
Identifier
SPE2DP-26-T-2848
NAICS
424210
This opportunity involves the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain's procurement of Meloxicam Tablets for delivery to multiple military locations: - Government Buyer: - Defense Logistics Agency (DLA), DLA Troop Support Medical Supply Chain Pharm FSA - Contracting office at 700 Robbins Avenue, Philadelphia, PA - OEMs and Vendors: - EXELAN PHARMACEUTICALS INC (NDC76282-0153-01) - ZYDUS PHARMACEUTICALS (USA) INC. (NDC68382-0051-01) - XLCARE PHARMACEUTICALS INC (NDC72865-0138-01) - Products Requested: - Meloxicam Tablets, 15 mg, 100 tablets per bottle (NSN 6505-01-541-3243) - Total quantity: 14 bottles across multiple line items and delivery locations - Specific part numbers and quantities per OEM: - EXELAN PHARMACEUTICALS INC: NDC76282-0153-01 (6 bottles) - ZYDUS PHARMACEUTICALS (USA) INC.: NDC68382-0051-01 (6 bottles) - XLCARE PHARMACEUTICALS INC: NDC72865-0138-01 (2 bottles) - Delivery Locations: - USS Patriot MCM 7 (FPO AP 96675) - Rose Barracks, Vilseck, Germany (92249) - USS Lewis B Puller ESB 3 (FPO AE 09591) - USS California SSN 781 (FPO AE 09566) - Notable Requirements: - Strict packaging and marking per Medical Marking Standard No. 1A - Hazardous material handling requirements - Compliance with NIST SP 800-171 cybersecurity assessments - Delivery required within 5 days of order - Prompt payment and inspection at destination
Description
MELOXICAM TABLETS (QTY: 2, NSN: 6505-01-541-3243, Purchase Request: 7016288917) Approved Sources: - CAGE: 6GFC4, Part No: NDC76282-0153-01, Company: EXELAN PHARMACEUTICALS INC - CAGE: 6YA44, Part No: NDC68382-0051-01, Company: ZYDUS PHARMACEUTICALS (USA) INC. - CAGE: 86SL9, Part No: NDC72865-0138-01, Company: XLCARE PHARMACEUTICALS INC
MELOXICAM TABLETS (QTY: 5, NSN: 6505-01-541-3243, Purchase Request: 7016288919) Approved Sources: - CAGE: 6GFC4, Part No: NDC76282-0153-01, Company: EXELAN PHARMACEUTICALS INC - CAGE: 6YA44, Part No: NDC68382-0051-01, Company: ZYDUS PHARMACEUTICALS (USA) INC. - CAGE: 86SL9, Part No: NDC72865-0138-01, Company: XLCARE PHARMACEUTICALS INC
MELOXICAM TABLETS (QTY: 1, NSN: 6505-01-541-3243, Purchase Request: 7016297185) Approved Sources: - CAGE: 6GFC4, Part No: NDC76282-0153-01, Company: EXELAN PHARMACEUTICALS INC - CAGE: 6YA44, Part No: NDC68382-0051-01, Company: ZYDUS PHARMACEUTICALS (USA) INC. - CAGE: 86SL9, Part No: NDC72865-0138-01, Company: XLCARE PHARMACEUTICALS INC
MELOXICAM TABLETS (QTY: 4, NSN: 6505-01-541-3243, Purchase Request: 7016297292) Approved Sources: - CAGE: 6GFC4, Part No: NDC76282-0153-01, Company: EXELAN PHARMACEUTICALS INC - CAGE: 6YA44, Part No: NDC68382-0051-01, Company: ZYDUS PHARMACEUTICALS (USA) INC. - CAGE: 86SL9, Part No: NDC72865-0138-01, Company: XLCARE PHARMACEUTICALS INC
MELOXICAM TABLETS (QTY: 1, NSN: 6505-01-541-3243, Purchase Request: 7016296935) Approved Sources: - CAGE: 6GFC4, Part No: NDC76282-0153-01, Company: EXELAN PHARMACEUTICALS INC - CAGE: 6YA44, Part No: NDC68382-0051-01, Company: ZYDUS PHARMACEUTICALS (USA) INC. - CAGE: 86SL9, Part No: NDC72865-0138-01, Company: XLCARE PHARMACEUTICALS INC
MELOXICAM TABLETS (QTY: 1, NSN: 6505-01-541-3243, Purchase Request: 7016283085) Approved Sources: - CAGE: 6GFC4, Part No: NDC76282-0153-01, Company: EXELAN PHARMACEUTICALS INC - CAGE: 6YA44, Part No: NDC68382-0051-01, Company: ZYDUS PHARMACEUTICALS (USA) INC. - CAGE: 86SL9, Part No: NDC72865-0138-01, Company: XLCARE PHARMACEUTICALS INC